Clinical Trial Update: A Study of the Pharmacokinetics and Safety of CS0159 in Subjects With Hepatic Injury [Phase 1]

View source ↗

Summary

A Phase 1 trial update on the pharmacokinetics and safety of the investigational drug CS0159 in subjects with hepatic injury, including those with primary bilia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• CS0159

Snippet

Sponsor: Cascade Pharmaceuticals, Inc | Conditions: Primary Biliary Cholangitis | Phase 1 | Status: COMPLETED